ABOUT US

LYSINE BIOTECH Private Limited (LBPL) is an intellectual property (IP) driven company committed to formulation of drugs, vaccines, diagnostics of infectious agents (RT-PCR, rapid test antigen & ELISA) and range from DNA and Protein sequence target specific (N-terminal and C-terminal) based on antibody epitope prediction for rapid test antigen and antibody to peptide/protein drugs up to vaccines as well as gene therapy products.

Technical strength: Bioinformatics, Biotechnology, organic and biochemistry, three dimensional (3D) computer graphics for modelling, bio images and artificial intelligence.

Target identification and validation, hit identification, hit to lead, lead optimization, and IND enabling studies with integration into development.

Strong focus on IP protection and safety.

Strong capabilities in new scientific platforms including gene therapies, Insoluble drug delivery technologies, Antimicrobial drug resistance bi & tri specific antibiotics, antifungal and antibody conjugates and Industrial (Chemicals and Enzymes).

Expertise across therapeutic areas: Diabetics, oncology, immunology, neuroscience, infectious diseases, cardiovascular and metabolism, Antimicrobial drug resistance (Bacterial & Fungal), inflammation, and rare/orphan diseases.

Room No 209, First Floor, Periyar Technology Business Incubator, Periyar Maniammai Institute of Science and Technology (PMIST) Periyar Nagar, Vallam, Thanjavur- 613 403, Tamil Nadu, India. Innovations in life sciences are critical to Make in Tamilnadu with in India Read More About PERIYAR-TBI